Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Cyclerion Therapeutics, Inc.
13G/A
CYCN · 23255M105
|
0% |
2/12/2025
Event 12/31/2024
|
|||
| MFN Partners, LP | 0% | ||||
| MFN Partners GP, LLC | 0% | ||||
| MFN Partners Management, LP | 0% | ||||
| MFN Partners Management, LLC | 0% | ||||
| Michael F. DeMichele | 0% | ||||
| Farhad Nanji | 0% | ||||